Prevention of Thrombotic Events in MPN: Insights from Prof. Martin Ellis

At the 4th MPN Spring Symposium, Prof. Martin Ellis and specialists discussed the prevention of thrombotic events in myeloproliferative neoplasms (MPNs), particularly in polycythemia vera (PV). They emphasized the need for a multidisciplinary approach in managing thrombotic risks, highlighting genetic monitoring (JAK2, CALR, MPL) and treatment strategies such as antithrombotic therapy, aspirin, and phlebotomy.

In the video discussion, experts explored the importance of personalized disease management and the challenges of research, particularly in pediatric patients with PV. They also discussed international collaborations to advance MPN care and personalized therapies based on genetics.

For those interested in gaining a deeper understanding of these important insights, the full video is available at MPN World. You can register now for free to access exclusive content, patient testimonies, and more, and join a growing community of individuals focused on advancing MPN knowledge and care.